Switch to:
More From Other Websites
OPKO Health Supports National Prostate Cancer Council Legislation Sep 29 2014
OPKO Health (OPK) Reports Positive Data on Rayaldee Trial Sep 24 2014
OPKO's Second Rayaldee Phase 3 Trial Meets Primary Endpoints Sep 23 2014
OPKO Launches the 4Kscore Test in Europe Sep 15 2014
Opko (OPK) Sees Hammer Chart Pattern: Time to Buy? Sep 12 2014
Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be... Sep 11 2014
TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant Sep 09 2014
OPKO Licensee TESARO Submits New Drug Application for Rolapitant Sep 08 2014
OPKO HEALTH, INC. Financials Aug 19 2014
'Mad Money' Lightning Round: Don't Buy IBM Right Now Aug 14 2014
Opko’s Frost Discusses Treatment of Kidney Disease (Audio) Aug 13 2014
Taking Stock: Manley on Markets, Frost on Biotech (Audio) Aug 12 2014
Taking Stock: Manley on Markets, Frost on Biotech Aug 12 2014
OPKO HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 12 2014
OPKO HEALTH, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
OPKO Announces Second Quarter Operating and Financial Results Aug 11 2014
Rayaldee Phase 3 Trial Meets Primary Endpoints Aug 11 2014
Q2 2014 Opko Health Inc. Earnings Release - After Market Close Aug 11 2014
OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy Aug 07 2014
OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11,... Aug 07 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK